-
Mashup Score: 26Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy - 7 month(s) ago
Abstract. Mavacamten is a first-in-class, targeted, cardiac-specific myosin inhibitor approved by the US Food and Drug Administration for the treatment of adult
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4Viz.ai | AI-Powered Care Coordination - 8 month(s) ago
Viz.ai closes the gaps between patients, clinicians, and life-saving treatments with its leading-edge AI-powered care coordination solution.
Source: www.viz.aiCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @viz_ai https://t.co/JFfL3BiP3K has received a #DeNovo approval by the #FDA for its #VizHCM module, a #hypertrophic #cardiomyopathy #artificialintelligence detection algorithm: https://t.co/NO58MgVPlU
-
-
Mashup Score: 5
AbstractAims. Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity that is partly explained by the diversity of genetic variants contr
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
🫀The #genetic architecture of #Hypertrophic #cardiomyopathy #HCM in #Egyptian pts: 🧬Minor #Genes could be more relevant than in other populations Congratulations @aguib_y & coll. More 👉https://t.co/1kD2wG2ste @ehj_ed @ESC_Journals @rladeiraslopes @DrMagdiYacoub @ShehabAnwer https://t.co/o0LzAP4lyP
-
-
Mashup Score: 7Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments - 1 year(s) ago
Abstract. Heart failure with preserved ejection fraction (HFpEF) is a major driver of cardiac morbidity and mortality in developed countries, due to ageing popu
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments. Read more in EHJ! https://t.co/jf7V8uTS9V #HFpEF #Hypertrophic #Fabry #Amyloidosis #Drug #cardiotwitter @ESC_Journals @escardio https://t.co/bBJGAKlt42
-
-
Mashup Score: 0Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy - 1 year(s) ago
AbstractAims. Obstructive hypertrophic cardiomyopathy (oHCM) is characterized by dynamic obstruction of the left ventricular (LV) outflow tract (LVOT). Although
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
🫀 #LV obstruction determinants in #HCM #hypertrophic #cardiomyopathy 💚septal hypertrophy 💚apical dilatation 💚LV lengthening 💚LVOT inward remodelling 💚#genetics 👉https://t.co/SIGtT7d7V9 all the details @EACVIPresident @pablolamata @DesaiMilindY @alyoung62 @RinaAriga @BR_CMR https://t.co/bM6AsRL8IW
-
-
Mashup Score: 1Hypertrophic cardiomyopathy in identical twins: a case series - 1 year(s) ago
AbstractBackground. Hypertrophic cardiomyopathy in identical twins is rare. Cases of hypertrophic cardiomyopathy with homogenous and heterogeneous phenotypes ha
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
📚#EHJCaseReports - #Hypertrophic #cardiomyopathy 🫀 in identical #twins 👨👩👦👦 #genetics #CardioTwitter https://t.co/OCh7av5MLc @EHJCREiC @cfcamm @KardiologieHH @aayshacader @TJ_Yeo @ANazmiCalik @FarhanaAra @StefanoNistri @CrottiLia @glimongelli @MondaEmanuele @BondueAntoine https://t.co/57tio4Cpiv
-
-
Mashup Score: 0Risk of incident mental disorders in hypertrophic cardiomyopathy: a nationwide propensity-matched study - 1 year(s) ago
AbstractAims. We sought to determine the risk of mental disorders in patients with hypertrophic cardiomyopathy (HCM) compared with those without HCM.Methods and
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
🫀 &🧠in #hypertrophic #cardimyopathy 💚4046 #HCM pts 💚4.1 yrs fu 💚increased risk of mood & #anxietydisorders #CardioTwitter #mentalillness #EAPC_ESC #genetics https://t.co/PxxZsDo8XC @m_piepoli @glimongelli @MondaEmanuele @Bondue @FranBermudz @IacopoOlivotto @ImazioMassimo https://t.co/FxwyRgDSEb
-
-
Mashup Score: 4Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2022 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
#Competitive #sport is possible in a select group of low risk adult ##athletes with #hypertrophic #cardiomyopathy. No adverse events and no change in cardiac morphology @BasuJoyee @MichaelPapadak2 @gherardobis @DrMaiteTome @StGeorgesUni https://t.co/DsHl6EPzhx
-
-
Mashup Score: 0Molecular Heart Mapping and Cripsr Technology Create New Possibilities for Health Science - 2 year(s) ago
July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details of the heart at the cellular level. What if we could zoom in even further, via single nucleus profiling, to peer inside the heart with a molecular view? Imagine the incredible possibilities of such a detailed map: With this knowledge, doctors will be better able to diagnose and…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor New study, “Single-nucleus profiling of human dilated and #hypertrophic #cardiomyopathy” identified molecular alterations in failing #hearts at single-cell resolution, by performing single-nucleus #RNA sequencing of nearly 600,000 nuclei: https://t.co/4oEY2irE5h #MMRI
-
-
Mashup Score: 0Diagnosis and Treatment at Memorial Cardiac and Vascular Institute Eliminates Patient's Risk of 'Sudden Cardiac Death' - 2 year(s) ago
July 11, 2022 — Rod was diagnosed with cancer, but it wasn’t his most urgent medical issue. A few months after that diagnosis, and with his heart rate “going berserk,” according to his daughter, Rebecca, Rod was taken to the emergency room. There it was discovered he had an arrythmia, but even that wasn’t his biggest problem. “Rod was hospitalized because of the arrythmia, even though at first…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor A #cardiac #MRI and collaboration between multi-disciplinary specialists determined the patient had #hypertrophic #cardiomyopathy, a life-threatening, genetic condition that can sometimes have no symptoms: https://t.co/bNhyc3HnPi
-
Mavacamten, a myosin inhibitor, is the first disease-specific treatment for obstructive hypertrophic cardiomyopathy. Read more in #EHJ. https://t.co/09mpPm2fOv #hypertrophic #cardiomyopathy #myosin #cardiotwitter @ESC_Journals @escardio https://t.co/3IWavg3LwN